Advertisement
U.S. markets close in 49 minutes

MedX Health Corp (MDX.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.0650-0.0050 (-7.14%)
As of 02:55PM EDT. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0700
Open0.0700
Bid0.0650 x 0
Ask0.0700 x 0
Day's Range0.0650 - 0.0700
52 Week Range0.0300 - 0.0900
Volume110,000
Avg. Volume116,600
Market Cap17.027M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateApr 29, 2024 - May 03, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MDX.V

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      MedX Health and Health Partners announce the successful results of its pilot project in the United Kingdom and move towards a partnership agreement

      MISSISSAUGA, Ontario, February 28, 2024--MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce they have successfully completed the pilot project with Health Partners. MedX and Health Partners are working together to begin the roll-out of this service to targeted clients engaged in a preventative approach to health care management.

    • Business Wire

      MedX Health Corp. announces Dr. Paul Cohen as Medical Spokesperson

      MISSISSAUGA, Ontario, January 25, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society. He was awar

    • Business Wire

      MedX Announces Intention to Seek Acceptance for Amendment to Series I Convertible Loan Notes

      MISSISSAUGA, Ontario, December 12, 2023--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is making an Application to the TSX-V for Acceptance of the proposed amendment to the terms of the currently outstanding Convertible Loan Notes ("Series I Notes"). Following the conversion of five Series I Loan Notes during 2021, there are currently 75 Series I Loan Notes outstanding, with a face value of $3,750,000. The Series I Loan Notes, originally issued in the Fi